ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,610Medicare Part D Prescriptions Filled, Including Refills

Rank: 217 out of 1692

$645K Total Retail Price of All Prescriptions

Rank: 140 out of 1692

588 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 588 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 588 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 7,432 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LEVOTHYROXINE SODIUM 349 292 1 4
LISINOPRIL 328 268 2 2
SIMVASTATIN 283 261 3 1
METFORMIN HCL 265 247 4 8
LOVASTATIN 244 201 5 37
OMEPRAZOLE 199 152 6 5
HYDROCODONE-ACETAMINOPHEN 173 94 S3 7 6
ZOLPIDEM TARTRATE 158 99 8 23
HYDROCHLOROTHIAZIDE 153 152 9 9
FUROSEMIDE 144 109 10 7
AMLODIPINE BESYLATE 140 133 11 3
SYNTHROID 140 115 11 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 132 86 13 19
ATORVASTATIN CALCIUM 121 113 14 11
GABAPENTIN 120 74 15 13
LOSARTAN POTASSIUM 114 98 16 17
NEXIUM 110 80 17 25
CYMBALTA 109 81 18 51
SERTRALINE HCL 101 91 19 22
PREDNISONE 97 80 20 35
ALLOPURINOL 90 78 21 30
LOSARTAN-HYDROCHLOROTHIAZIDE 87 84 22 38
DIOVAN HCT 84 71 23 73
METOPROLOL TARTRATE 83 75 24 10
CIPROFLOXACIN HCL 81 54 25 65
AMITRIPTYLINE HCL 81 56 R 25 58
METOPROLOL SUCCINATE 80 75 27 18
CITALOPRAM HBR 79 71 28 21
PANTOPRAZOLE SODIUM 79 60 28 39
CEPHALEXIN 78 58 30 89
ATENOLOL 76 74 31 15
DIOVAN 72 66 32 42
AMLODIPINE BESYLATE-BENAZEPRIL 71 66 33 67
PRAVASTATIN SODIUM 71 68 33 12
TAMSULOSIN HCL 69 69 35 31
MORPHINE SULFATE ER 68 22 S2 36 121
OXYCODONE-ACETAMINOPHEN 67 30 S2 37 70
DONEPEZIL HCL 66 66 38 29
FLUTICASONE PROPIONATE 61 43 39 27
FLUOXETINE HCL 61 49 39 52
GLIMEPIRIDE 59 46 41 32
TRAZODONE HCL 59 21 41 33
TRAMADOL HCL 59 49 41 16
WARFARIN SODIUM 59 58 41 14
GLIPIZIDE 55 55 45 47
CRESTOR 54 34 46 26
OXYCODONE HCL-ACETAMINOPHEN 52 0 S2 47 94
GLIPIZIDE ER 51 48 48 87
CARVEDILOL 51 51 48 24
MIRTAZAPINE 50 30 50 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.